Shape 21 Experience
    Shape 21 Experience
      1. Home
      2. COVID-19 Testing

      COVID-19 Testing

      A full range of antibody, antigen and molecular SARS-CoV-2 tests

      Testing is key for the new normal

      Highly accurate testing at scale is essential as we move into the next phase​ of the pandemic. Whether the testing is done in laboratories across the globe​ or your local pharmacy, those tests must be of the highest quality, enabling safe movement throughout our communities.

      Now Available: High Throughput SARS-CoV-2 Ag (CoVAg) Assay1

      Improve your confidence in SARS-CoV-2 mass screening with a high-throughput, central lab-based antigen assay that can quickly confirm accurate results in at-risk individuals, including asymptomatic and early-disease patients. 

      Requirements for testing and managing COVID-19 patients will change over time

      Rapid and accurate testing on a massive scale is vital to address the challenges of the COVID-19 pandemic.

      COVID-19 Testing GraphicMolecular PCR and Antibody Tests*POC Antigen Test**Antibody Test*Vaccine DevelopmentSensitivity and Specificity Spike Protein

      Tools for assessing presence of the virus and for assessing immune status

      Siemens Healthineers continues to deliver high-value COVID-19 care across disciplines throughout the patient care pathway.

      Atellica

      Antibody Testing*

      Our SARS-CoV-2 antibody blood tests are well-positioned to aid vaccine development efforts – and now, our test quality and performance have been confirmed.

      FTD SarsCoV-2

      Molecular Testing*

      Molecular testing is critical to understanding an infectious​ disease outbreak, and our RT-PCR assay is fundamental to determining current infection.

      POC Testing

      Point of Care Testing**

      As society continues to navigate through the COVID-19 pandemic, there is a critical public health need to get ahead of the spread with a fast and simple test for all.​

      1

      This test has not been reviewed by the FDA. In the US, use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. Product availability may vary by country and is subject to regulatory requirements.

      * These SARS-CoV-2 molecular and serology tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. The molecular test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The serology test has been authorized only for detecting the presence of antibodies against SARS-CoV-2, not for any other viruses or pathogens. These tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. Product availability may vary from country to country and is subject to varying regulatory requirements.

      ** Not available for sale in the U.S. Product availability may vary by country.